Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
17 angezeigte Treffer · Seite 9, keine Gesamtzahl für „Emend“
Suchtreffer
Begriffe & Kennungen
Ivemend · 4.8 · Immune system disorders hypersensitivity reactions including not known anaphylactic reactions Metabolism and n
Eintrag öffnenIvemend · 4.8 · In an additional active-controlled clinical study in 1,169 adult patients receiving aprepitant and HEC, the ad
Eintrag öffnenIvemend · 4.8 · Non-CINV studies Additional adverse reactions were observed in adult patients treated with aprepitant for post
Eintrag öffnenIvemend · 4.8 · Oral aprepitant The most common adverse reactions reported at a greater incidence in adults treated with the a
Eintrag öffnenIvemend · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenIvemend · 4.8 · Summary of the safety profile In clinical studies, various formulations of fosaprepitant have been administere
Eintrag öffnenIvemend · 4.8 · System organ class Adverse reaction Frequency Infection and infestations candidiasis, staphylococcal infection
Eintrag öffnenIvemend · 4.8 · System organ class Adverse reaction Frequency Vascular disorders flushing, thrombophlebitis (predominantly, un
Eintrag öffnenIvemend · 4.8 · Table 5: Tabulated list of adverse reactions – aprepitant
Eintrag öffnenIvemend · 4.8 · Table 6: Tabulated list of adverse reactions – fosaprepitant
Eintrag öffnenIvemend · 4.8 · Tabulated list of adverse reactions - aprepitant The following adverse reactions were observed in a pooled ana
Eintrag öffnenIvemend · 4.8 · Tabulated list of adverse reactions – fosaprepitant The following are adverse reactions reported in adult pati
Eintrag öffnenIvemend · 4.8 · The frequency categories given in the table are based on the studies in adults; the observed frequencies in th
Eintrag öffnenIvemend · 4.8 · The most common adverse reactions reported at a greater incidence in paediatric patients treated with the apre
Eintrag öffnenIvemend · 4.8 · The safety of the 1-day IV regimen was supported by a pooled analysis of 3 active-controlled clinical studies
Eintrag öffnenIvemend · 4.8 · The safety of the 3-day IV regimen is supported by a single arm clinical study in 100 paediatric patients (age
Eintrag öffnenIvemend · 4.8 · The safety profile of fosaprepitant in adult and paediatric patients was generally similar to that observed wi
Eintrag öffnen